PA
BMY icon

Procyon Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Procyon Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$963K Sell
16,718
-1,469
-8% -$84.4K 0.04% 277
2026
Q1 		$1.1M Buy
18,187
+2,735
+18% +$159K 0.05% 259
2025
Q4 		$833K Sell
15,452
-20,349
-57% -$979K 0.04% 285
2025
Q3 		$1.61M Buy
35,801
+8,907
+33% +$416K 0.1% 171
2025
Q2 		$1.24M Sell
26,894
-1,529
-5% -$75.1K 0.12% 163
2025
Q1 		$1.73M Buy
28,423
+9,763
+52% +$569K 0.1% 193
2024
Q4 		$1.06M Buy
18,660
+1,423
+8% +$79.5K 0.07% 232
2024
Q3 		$891K Buy
17,237
+572
+3% +$26.8K 0.06% 252
2024
Q2 		$692K Buy
16,665
+1,858
+13% +$83.1K 0.05% 269
2024
Q1 		$803K Buy
14,807
+5,595
+61% +$285K 0.06% 253
2023
Q4 		$473K Sell
9,212
-4,350
-32% -$228K 0.04% 323
2023
Q3 		$787K Buy
13,562
+2,135
+19% +$131K 0.08% 224
2023
Q2 		$731K Buy
11,427
+1,487
+15% +$99.7K 0.09% 207
2023
Q1 		$689K Sell
9,940
-645
-6% -$45.5K 0.11% 172
2022
Q4 		$762K Buy
10,585
+1,365
+15% +$103K 0.14% 152
2022
Q3 		$655K Sell
9,220
-2,756
-23% -$200K 0.16% 127
2022
Q2 		$922K Sell
11,976
-3,646
-23% -$278K 0.2% 106
2022
Q1 		$1.14M Buy
15,622
+4,946
+46% +$332K 0.24% 92
2021
Q4 		$666K Buy
10,676
+5,548
+108% +$325K 0.14% 141
2021
Q3 		$303K Buy
5,128
+61
+1% +$4.02K 0.08% 233
2021
Q2 		$339K Sell
5,067
-676
-12% -$44.1K 0.09% 190
2021
Q1 		$363K Sell
5,743
-298
-5% -$18.5K 0.16% 147
2020
Q4 		$375K Sell
6,041
-118
-2% -$7.26K 0.18% 136
2020
Q3 		$371K Buy
6,159
+21
+0.3% +$1.26K 0.21% 116
2020
Q2 		$361K Buy
6,138
+357
+6% +$21.4K 0.19% 110
2020
Q1 		$322K Sell
5,781
-43
-0.7% -$2.63K 0.21% 99
2019
Q4 		$374K Buy
+5,824
New +$334K 0.23% 96

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Procyon Advisors's BMY Position: Q2 2026 in Review

Procyon Advisors reduced its Bristol-Myers Squibb (BMY) stake by 8.1% in Q2 2026, selling an estimated $84.4K and leaving 16,718 shares worth $963K. The position accounts for 0.04% of the portfolio, ranked #277.

Procyon Advisors first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.73M in Q1 2025. 895 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Procyon Advisors held 16,718 shares of Bristol-Myers Squibb worth $963K as of Q2 2026.
  • Procyon Advisors sold 1,469 Bristol-Myers Squibb shares in Q2 2026, an estimated $84.4K.
  • Bristol-Myers Squibb made up 0.04% of Procyon Advisors's portfolio in Q2 2026, its #277 holding.
  • Procyon Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Bristol-Myers Squibb position peaked at $1.73M in Q1 2025.
  • 895 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.